Development and validation of the Myasthenia Gravis TeleScore (MGTS).

Objective: The aim of our study was to validate the Myasthenia Gravis TeleScore (MGTS), a scale for the evaluation of MG patients in telemedicine.

Introduction: COVID-19 pandemic has boosted telemedicine in clinical practice. It could be crucial in the care of neurological patients with chronic disease.

Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).

Objective: To validate the Italian version of the Myasthenia Gravis Impairment Index (MGII).

Introduction: MGII is a recent promising measure developed for MG patient evaluation. It includes a clinical severity evaluation and a patient-reported questionnaire.

Outcome measures and treatment effectiveness in late onset myasthenia gravis.

Background: Recently different subtypes of myasthenia gravis (MG) have been described. They differ for clinical features and pathogenesis but the prognosis and response to treatment is less clear. The aim of the study was to evaluate outcome and treatment effectiveness including side effects in late onset MG (LOMG) compared with early onset MG (EOMG).